Retraction of statins article is not in the public interest: better characterisation of benefits and risks is crucial.
作者信息
Fahey Tom, Smith Susan
机构信息
Royal College of Surgeons in Ireland Medical School, Dublin 2, Republic of Ireland
Royal College of Surgeons in Ireland Medical School, Dublin 2, Republic of Ireland.
出版信息
BMJ. 2014 Jun 18;348:g4028. doi: 10.1136/bmj.g4028.
PMID:24943917
Abstract
摘要
相似文献
1
Retraction of statins article is not in the public interest: better characterisation of benefits and risks is crucial.
BMJ. 2014 Jun 18;348:g4028. doi: 10.1136/bmj.g4028.
2
Huffman and colleagues' response to Abramson and colleagues' article on statins in low risk people.
BMJ. 2014 Feb 26;348:g1520. doi: 10.1136/bmj.g1520.
3
Davis and Dietrich's response to Abramson and colleagues' article on statins in low risk people.
BMJ. 2014 Feb 26;348:g1795. doi: 10.1136/bmj.g1795.
4
The BMJ statins papers misrepresent the facts.
BMJ. 2014 Jun 18;348:g4030. doi: 10.1136/bmj.g4030.
5
Risks and benefits of statins in lupus erythematosus.
Arch Intern Med. 2004 Jan 12;164(1):107-8. doi: 10.1001/archinte.164.1.107-b.
6
Authors' reply to Huffman and colleagues.
BMJ. 2014 Feb 26;348:g1523. doi: 10.1136/bmj.g1523.
7
Authors' reply to Davis and Dietrich.
BMJ. 2014 Feb 26;348:g1792. doi: 10.1136/bmj.g1792.
8
Is cholesterol lowering with statins the gold standard for treating patients with cardiovascular risk and disease?
South Med J. 2003 Aug;96(8):837; author reply 837-8. doi: 10.1097/01.SMJ.0000084285.83054.1C.
9
Should people at low risk of cardiovascular disease take a statin?
BMJ. 2013 Oct 22;347:f6123. doi: 10.1136/bmj.f6123.
10
Risks in the balance: the statins row.
BMJ. 2014 Aug 7;349:g5007. doi: 10.1136/bmj.g5007.
Zotero 插件